Loading fund overlap…
3 of 69 unique stocks in common · Jaccard: 4.3%
A weighted portfolio overlap of 6.12% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹6.12 is allocated to the exact same companies at the same relative proportions. The schemes share 3 common holdings.
The largest overlapping asset in their portfolios is Ajanta Pharma, which commands a weight of 2.61% in UTI Focused Fund and 4.70% in UTI - Healthcare Fund. Holding both schemes increases your concentration in Ajanta Pharma rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in UTI Focused | in UTI - |
|---|---|---|
| Ajanta PharmaPharmaceuticals & Biotechnology | 2.61% | 4.70% |
| Aurobindo PharmaPharmaceuticals & Biotechnology | 2.07% | 1.88% |
| Global HealthHealthcare Services | 1.63% | 2.25% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.